DETECTCDX Trademark

Trademark Overview


On Tuesday, February 16, 2021, a trademark application was filed for DETECTCDX with the United States Patent and Trademark Office. The USPTO has given the DETECTCDX trademark a serial number of 90531146. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, May 14, 2024. This trademark is owned by ARUP Laboratories, Inc.. The DETECTCDX trademark is filed in the Medical Instrument Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical, medical biological and medical gene therapy testing to assess, analyze, determine and provide information regarding the effectiveness, side effects, benefits, safety, risk, toxicity, duration of use, use options and advisability of specific drugs and biological products

Medical, biological and gene therapy apparatus and testing kits to assist in collecting, assessing and determining optimal drugs and biological products for medical use, namely, specimen transport tubes for use with blood, genetic materials, fluids, tissues, samples and other human components and related elements, frozen specimen bags, specimen collection and transport instructions, foam coolers for specimens, emergency medical service foam coolers for specimens, cardboard shipping containers for specimens, and shipping labels for specimens
detectcdx

General Information


Serial Number90531146
Word MarkDETECTCDX
Filing DateTuesday, February 16, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 21, 2021

Trademark Statements


Pseudo MarkDETECT CDX ; DETECT COMPANION DIAGNOSTIC
Goods and ServicesMedical, medical biological and medical gene therapy testing to assess, analyze, determine and provide information regarding the effectiveness, side effects, benefits, safety, risk, toxicity, duration of use, use options and advisability of specific drugs and biological products
Goods and ServicesMedical, biological and gene therapy apparatus and testing kits to assist in collecting, assessing and determining optimal drugs and biological products for medical use, namely, specimen transport tubes for use with blood, genetic materials, fluids, tissues, samples and other human components and related elements, frozen specimen bags, specimen collection and transport instructions, foam coolers for specimens, emergency medical service foam coolers for specimens, cardboard shipping containers for specimens, and shipping labels for specimens

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, May 19, 2021
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameARUP Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Party NameARUP Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSalt Lake City, UT 84108

Trademark Events


Event DateEvent Description
Saturday, July 3, 2021LETTER OF SUSPENSION E-MAILED
Friday, February 19, 2021NEW APPLICATION ENTERED
Wednesday, May 19, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, June 26, 2021ASSIGNED TO EXAMINER
Saturday, July 3, 2021SUSPENSION LETTER WRITTEN
Saturday, July 3, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 13, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 9, 2021TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, August 13, 2021ASSIGNED TO LIE
Friday, August 13, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, September 21, 2021PUBLISHED FOR OPPOSITION
Friday, August 13, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 1, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, September 21, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, May 16, 2022SOU EXTENSION 1 GRANTED
Monday, May 16, 2022SOU TEAS EXTENSION RECEIVED
Monday, May 16, 2022SOU EXTENSION 1 FILED
Friday, October 28, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 28, 2022SOU EXTENSION 2 FILED
Friday, October 28, 2022SOU EXTENSION 2 GRANTED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, November 1, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU EXTENSION 3 FILED
Monday, May 8, 2023SOU EXTENSION 3 GRANTED
Thursday, November 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, November 16, 2023SOU EXTENSION 4 FILED
Thursday, November 16, 2023SOU EXTENSION 4 GRANTED
Tuesday, May 14, 2024SOU EXTENSION 5 FILED
Tuesday, May 14, 2024SOU EXTENSION 5 GRANTED
Tuesday, May 14, 2024SOU TEAS EXTENSION RECEIVED
Saturday, November 18, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED